APP and Alzheimer disease: In addition to cholinergic dysfunction and the well-known Abeta (Aβ) and Tau pathology of AD, inflammation, oxidative stress, as well as, e.g., alterations in lipid and energy metabolism are also involved in the pathogenesis of AD.